Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiationJoseph Panoff, Jean L. Wright, Leonidas G. Koniaris et al.|Breast Cancer Research and Treatment|2011Cited by 88
The use of neoadjuvant platinum-based chemotherapy in locally advanced breast cancer that is triple negative: retrospective analysis of 144 patientsJudith Hurley, Mark D. Pegram, José Pablo Leone et al.|Breast Cancer Research and Treatment|2013Cited by 87
Predictors of locoregional outcome in patients receiving neoadjuvant therapy and postmastectomy radiationJean L. Wright, Judith Hurley, Cristiane Takita et al.|Cancer|2012Cited by 48
Higher Chest Wall Dose Results in Improved Locoregional Outcome in Patients Receiving Postmastectomy RadiationJoseph Panoff, Jean L. Wright, V. Gunaseelan et al.|International Journal of Radiation Oncology*Biology*Physics|2011Cited by 26
Risk Factors for Locoregional Failure in Patients With Inflammatory Breast Cancer Treated With Trimodality TherapyKunal Saigal, Jean L. Wright, Judith Hurley et al.|Clinical Breast Cancer|2013Cited by 24